CNFA — Canafarma Hemp Products Income Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Annual income statement for Canafarma Hemp Products, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2017 June 30th | 2018 June 30th | 2019 June 30th | 2020 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 0 | 1.8 |
| Cost of Revenue | ||||
| Gross Profit | — | — | — | -1.12 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 0.001 | 0.007 | 0.026 | 19 |
| Operating Profit | -0.001 | -0.007 | -0.026 | -17.2 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.001 | -0.007 | -0.026 | -19 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.001 | -0.007 | -0.026 | -19 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.001 | -0.007 | -0.026 | -17.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.001 | -0.007 | -0.026 | -17.8 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0 | -0 | -0 | -0.081 |
| Dividends per Share |